Summary Clinical science in the UK has been presented with a range of opportunities and new initiatives in recent years. This review summarizes the contribution of clinical scientists to the changing face of laboratory medicine, and describes some recent UK Government initiatives to modernize the scientific service and develop the people who work in it. Recent changes in the regulation of professional practice and the need for maintenance of professional competence are also discussed.
Introduction
Clinical science enters the 21st century with a mixed collection of baggage. On the one hand, the high level of public interest in the human body and in healthcare in general, coupled with significant, well-publicised scientific advances such as the Human Genome Project or stem cell research, create a climate that should attract good scientists into clinical science. On the other hand, an increasing distrust of both scientists and the medical profession, and the continuing perception of a ÔThird World health serviceÕ is in danger of diminishing public confidence and driving potential recruits away.
The UK Government's blueprint for the modernized National Health Service (NHS), the NHS Plan, issued in July 2000 (Department of Health, 2000) , envisaged widespread changes to the nature of the NHS. It promised more staff, better pay and conditions and more flexible, patient-orientated care, in addition to abolishing traditional demarcations between disciplines in favour of an integated, multiskilled approach centred on the needs of patients rather than professionals. The NHS Plan also set out proposals for the radical modernization of staff education and training, with much greater use of electronic learning and information technology, and the promise of Individual Learning Accounts (personalized funding packages) for all staff working in the service.
Future direction of laboratory medicine
Laboratory Medicine services are a vital part of the delivery of healthcare. It has been estimated that 60% of medical decisions depend on laboratory data and such data represents over 70% of the data contained in patient records (Becich, 2000) . The NHS Plan (Department of Health, 2000) envisages new ways of working which will be impossible without improved access to laboratory diagnostic services. Paragraph 4.4 states:
ÔStaff and patients will experience new ways of working which will blur the boundaries between primary and secondary care. Specific elements of this new service will include:
• Fast access to diagnostics and pathology leading to effective interventions …Õ These changes in the UK NHS must be considered alongside the developments in laboratory medicine that affect practice all over the world. The Foresight Healthcare report, produced by the UK Department of Trade & Industry in 2000, with the object of envisioning healthcare in the year 2020 (Foresight Healthcare Panel, 2000) commented:
ÔBy 2020 diagnostics will have been placed on a fundamentally different and more rational basis. Much of current practice is not underpinned by evidence, unnecessary tests are carried out and there are issues of sensitivity, specificity and quality assurance.Õ Most developed healthcare economies are seeking a much sounder evidence base for clinical practice, and clinical scientists have a crucial and developing role in producing the evidence necessary to sustain the more rational approach to healthcare. Technological advances are also changing the nature of the discipline, as the Foresight report (Foresight Healthcare Panel, 2000) makes clear:
ÔThe use of advanced information and communication technologies will permit tele-diagnosis and centralization of complex and expensive diagnostic services. At the same time, engineering advances will lead to … diagnostic methods that can be used in the community and home environment.Õ The need to centralize complex and expensive services and the need to bring diagnostics as close and accessible to patients as possible are opposing trends that create particular strains on the traditional clinical laboratory serving a population of 0.2-0.6 million people. Such a laboratory increasingly finds itself too small to provide the specialist and complex diagnostic services required to support modern medicine, and has to look to larger units for support in this respect. At the same time, the burden of trying to monitor and support all the near-patient devices (blood glucose sensors, blood coagulation analysers for anticoagulant monitoring, haemoglobinometers, blood gas analysers) required at the point of care is proving more and more difficult to manage. The Department of Health's Pathology Modernization Project for England (Department of Health, 1999) recognizes this tension by suggesting that future diagnostic services must be based around larger populations (greater than one million people, with a figure of two million being suggested as a reasonable size). Combining the advantages of larger scale with the need for local contact and accessibility for patients will necessitate (in most UK settings) a group of laboratories working together as a network, collaborating on the specialized aspects of the work by designating a single centre as the lead centre for a particular specialty, and concentrating expertise and equipment at that point, while maintaining local clinical contact and support for testing in the community through a network of local laboratories. In urban conurbations, a Ôhub and spokeÕ or Ôdual hubÕ model may be appropriate, in which a large central laboratory provides all the specialized support, and satellite laboratories (essential services laboratories) in the environs provide near-patient services. However, more rural locations may best be served by a ÔnecklaceÕ of equally sized laboratories in the main population centres, each of which serves its local population and provides some aspect of specialist service to the network. Whichever model is deemed more appropriate for a particular situation, networks (designed to be closely related to the clinical networks they serve) will undoubtedly provide the future of laboratory medicine, and have significant advantages in terms of gathering a critical mass of clinical scientists in one location or organization, rather than the present rather piecemeal distribution found in many disciplines.
Access to diagnostic services, at one time exclusively the province of doctors, is also becoming more open. Paragraph 9.5 of the NHS Plan (Department of Health, 2000) states:
ÔThe new approach [to ways of working] will shatter the old demarcations which have held back staff and slowed down care. NHS employers will be required to empower appropriately qualified nurses, midwives and therapists to undertake a wider range of clinical tasks, including the right to … order investigations and diagnostic tests.Õ This increased access by health professionals, and the prospect of allowing patients to have direct access to diagnostic services (already a reality in some countries) will inevitably increase the workload of those staff who are trained and qualified to provide advice on the selection of tests and the interpretation of results. We will no longer be able to assume (if we ever could!) that those who request diagnostic tests have a clear understanding of their uses and limitations. Much more liaison will be required, provided through personal contact or, increasingly, through information technology. Writing and developing this information and disseminating it through the wider medical community and to patients themselves will be an increasingly important part of the work of appropriately trained clinical scientists.
There is also a wider challenge in terms of information management. Laboratory medicine services are seeing a considerable degree of convergence at the technological level. All disciplines now make use of similar technologies, such as immunological or molecular biology techniques, and the traditional boundaries between disciplines at the Clinical scientists in laboratory medicine analytical level are becoming much more blurred. Multidisciplinary or technique-centred laboratories are becoming commonplace. However, the knowledge base required to provide analytical or interpretative support to these areas is diverging rapidly. The days of the general pathologist who could oversee all parts of the laboratory are long gone, and an individual who has qualified as a haematologist or clinical biochemist cannot now hope to be able to provide specialist support to the required level in all aspects of the discipline; subspecialization in, for example, coagulation disorders or haematological oncology is necessary, and further sub-subspecialization is becoming increasingly important. The provision of highquality information and decision support to make properly validated specialist information accessible to laboratory professionals across the network and clinicians operating at the patient interface is a sine qua non for laboratory medicine in the 21st century.
The above introductory remarks have sought to describe the background changes affecting laboratory medicine and to indicate the changing and expanding role of the clinical scientist within the laboratory medicine team. It is now appropriate to consider the overall role of scientifically qualified personnel within laboratory medicine, and to examine the training and qualifications that this role requires.
Role of the clinical scientist
The main roles of clinical scientists are summarized in Table 1 . These roles do not necessarily define a profession, many of them are currently carried out by medical practitioners, those currently graded as biomedical scientists and those currently graded as clinical scientists. There is no particular need to restrict them to a specific group of people with a separate salary scale, different terms and conditions of service, etc. However, it is vital that these roles are recognized as essential to the development of laboratory medicine, that those who undertake them (whatever their original background) are properly trained and certified as competent to fulfil them, and that the levels of remuneration and career structure are adequate to attract and retain high quality scientists in laboratory medicine.
The skills, knowledge and abilities (often collectively referred to as competencies) required to fulfil the roles in Table 1 have been defined for the majority of clinical scientist modalities (haematology, biochemistry, medical physics, etc.) as a necessary element of registration to practice. They can be divided into scientific competencies, clinical competencies, technical competencies, research and development competencies, problem-solving skills and management competencies. The professional bodies representing each clinical science modality in the UK have agreed to a common template of generic competencies, which can then be applied to individual modalities. An example of the approach is shown in Table 2 . The competency sets also contain detail of how individual competencies are acquired (i.e. the methods of training) and how they are assessed (i.e. how an individual can demonstrate acquisition of a particular skill or area of knowledge).
Definition and maintenance of such competency sets for all healthcare science professions is a considerable undertaking, but this is essential to enable flexibility in career structures and define the mechanism for transfer between different job roles or extension of professional roles. The existence of competency sets related to specific roles allows individuals who wish to fulfil those roles to define the areas of training they require, and protects the patient by ensuring that those who undertake a particular role do so with validated competence to practice.
The National Occupational Standards Project for Healthcare Scientists (http://www.noshcs.co.uk) is a 4-year project that began in 2000, which sets out to shape the future development of competence-based training for all workers in the scientific health professions. Once competencies have been defined across the whole field of healthcare science, we will have a sound basis for the flexible career structures and pathways envisaged in Making the Change, the human resource strategy document for healthcare science workers, published in 2001 (Department of Health 2001a) .
Making the change: human resource strategy for healthcare scientists Making the Change is an important document which sets out the UK Government's vision for some 40 000 people working in healthcare science at various levels and in (Table 3) . It deals with ways to improve the supply of scientific staff so that adequate numbers of professional staff are available to deliver a high quality service, ways to strengthen education and training to ensure that staff are trained fit for purpose and committed to professional development and plans to introduce a robust regulatory structure to enhance public confidence in the healthcare science professions. It also sets out proposals to value staff for the work they do, improve the working environment and develop attractive career pathways so that high quality scientists can be recruited and retained.
The recruitment and retention problem has become particularly acute in recent years. For biomedical scientists, a survey conducted in 2000 by the Institute for Biomedical Science (Gillett Consultancy, 2000) indicated that 88% of all NHS laboratories felt that they were understaffed, and 62% had current unfilled vacancies. The overall shortfall of biomedical scientists for England and Wales was estimated at 1255 posts, of which over 1000 were at the MLSO 1 grade. The position in other areas of laboratory medicine is little better, the training capacity for clinical biochemists is currently half of that required simply to keep pace with retirements over the next 10 years, let alone to meet the increasing demand for those with scientific and interpretative skills and the other competencies referred to above. Medical staff in disciplines such as haematology and clinical biochemistry have an increasingly clinical role. This has left a gap in the laboratory which needs to be filled by appropriately trained clinical scientists.
The problem must be addressed in a number of different ways. There can be no doubt that payscales are the major problem for biomedical scientists, and more attractive pay structures will have to be developed if the staffing problems in this area are to be properly addressed. This aspect is currently being considered as part of the overall NHS pay modernization process, known as Agenda for Ability to provide interpretation of data and a diagnostic (therapeutic) opinion, including any further action to be taken by the individual responsible for the patient Understanding of the wider clinical situation relevant to the patients presenting to his/her specialty Ability to develop/devise an investigation strategy taking into account the complete clinical picture Understanding of the clinical applications of the speciality and the consequences of decisions made upon his/her actions/advice Awareness of the evidence base that underpins the use of the procedures employed by the service.
Specific competencies for haematology clinical scientists
Must understand the underlying mechanisms of the pathology of disease Must recognize and understand the value of laboratory based research and development in haematology in the practice of clinical science. Must be able to advise on choice of investigation Must be able to interpret data and recommend further course of action within the wider context of the clinical situation Must be able to relate data from other disciplines to the overall clinical situation Must be aware of the strengths and weaknesses of the evidence base for commonly used procedures and investigations Must be able to contribute to monitoring of patients as appropriate within haematology Must have sufficient clinical knowledge to be able to communicate effectively with clinical and other professional colleagues Attainment of these specific competencies requires the achievement of: An understanding of general clinical medicine and its application to the physiological systems of man An understanding of human physiology and the effects of disease on physiological processes An understanding of the effectiveness of therapies and drug interactions on physiological processes An understanding of the effects of pre-and postanalytical variables required for the appropriate clinical interpretation and assessment of diagnostic procedures in haematology These objectives are attained through: Participation in a nationally approved training programme (currently being developed) Secondment to specialist units where appropriate Participation in local seminars, clinical meetings, clinical audit and report evaluation Self endeavour (e.g. literature awareness) under the tutelage of an appropriate haematology specialist Attainment of the objectives is assessed by: The nominated local supervisor and a nationally appointed assessor
Change (Department of Health, 1998) and details are not yet available, although it appears that all healthcare scientists will be subsumed into a single pay spine, with progress along that spine being related to personal development and validated acquisition of competence, the Knowledge and Skills Framework, based on the concept of a Ôskills escalatorÕ (Department of Health, 2001b) (Figure 1 ). However, it is also necessary to develop flexible career structures that remove artificial barriers between professions but maintain the principles that individuals must receive specific training in the role for which they are to be employed, and must be required to demonstrate and maintain competence in that role. This process also encompasses the provision of enhanced career opportunities for those in support grades (e.g. medical laboratory assistant, cytoscreener), allowing them access to scientist grades via approved training programmes.
The scientist workforce will also need to be expanded to meet the changing requirements of the service and the increased demand for those with scientific and interpretative competence. The Association of Clinical Biochemists and Royal College of Pathologists recently estimated that a further 70 Consultant Clinical Scientist posts in clinical biochemistry are required to meet current UK needs (Association of Clinical Biochemists/Royal College of Pathologists, 2002) , in addition to a proportional expansion in medical consultant posts. Similar workforce planning exercises will be required for scientists in other disciplines, working closely with the National Workforce Development Board and the regional Workforce Development Confederations who will deliver the training posts.
Laboratory medicine also needs to rethink the skill mix required to meet the needs of the service in the 21st century. More widespread and more sophisticated automation and the expanding knowledge base has changed the balance of skills required. Manual technical skills are becoming less important as automation develops, and process control (operator) skills are becoming increasingly important. However, the service still needs those who have a trouble-shooting ability based on a fundamental understanding of the methods and procedures in use under the casing of the Ôblack boxÕ, and is increasingly reliant on those who can interpret and advise on the correct use of procedures. In addition, there will always be a need for those with research training to perform both fundamental and applied research in laboratory medicine in pathology networks. Networks will also require increasing numbers of service-based scientists who share the same intellectual framework as those who carry out basic research, to spot opportunities for clinical links and to bring research findings to the wider service in a coherent and evidence-based manner. The aim is to deliver a laboratory medicine workforce that can function as a multiskilled, multiprofessional team in which specialist expertise can be fostered and developed. Flexible working and the removal of artificial barriers are to be encouraged, as long as they do not result in Ôdumbing-downÕ the service, a workforce that knows less and less about more and more. The foundation is defined by competency sets appropriate to the role performed and the clinical service required, defined training needs based on these competency sets, explicit standards of practice, systems to ensure maintenance of competence and periodic assessment of competence to confirm continued ability to practice (ÔrevalidationÕ).
Regulation of professional practice
The latter considerations are also relevant to changes in regulation for the scientific workforce in the UK. The Clinical Scientists Board was originally established to register 10 separate modalities of clinical scientist (Table 4) . These disciplines are clearly not all encompassing, and there have been some difficulties in applying them to scientists in certain specialized areas such as electron microscopy and toxicology. These areas will need further work to determine whether they remain as submodalities to existing modalities or develop into separate modalities in their own right.
Like much else in the NHS, professional regulation is also changing, in part under the pressures caused by wellpublicised problems, such as cardiac surgery in Bristol and the retention of human tissue at Alder Hey Hospital in Liverpool. The NHS Plan (Department of Health, 2000) set out the guidelines for reform of regulatory bodies in healthcare. The primary requirements are that regulatory bodies become smaller and more patient-focused. They must contain much greater representation from the public and patients organizations than has hitherto been the case, as professionals have dominated regulatory bodies in the past. Procedures for investigation of complaints or incidents must become more immediate and transparent to the public, and the new regulatory bodies must have meaningful accountability to the public and to the NHS.
The UK General Medical Council (GMC) has already begun to respond to these imperatives (General Medical Council, 2001 ) and on 1 April 2002 the CPSM ceased to exist and was replaced by the new Health Professions Council (HPC). The structure and function of HPC was described in a consultation document published in 2001 (Department of Health, 2001c) , and was designed to meet the new requirements for regulatory bodies. The 12 separate Boards of CPSM, each dealing with a single profession, are replaced by a single uniprofessional Council with responsibility for some 120 000 practitioners (of which Clinical Scientists number approximately 4000). The Council has 25 members, of which 12 are professionals (one representative for each of the old CPSM Boards) and 12 are lay. There is provision for the Chair to be either professional or lay; the current Chair, Professor Norma Brook, is a physiotherapist. The constitution of HPC allows for a small professional majority (not exceeding one vote) on the Council and its subcommittees. Interestingly, the definition of ÔlayÕ in this context refers to anyone who is not and has never been a member of one of the professions covered by the Council, so medical practitioners count as lay representatives for these purposes.
As well as the greater public presence on HPC, the new Council has a broader scope of operation and new powers to deal with individual practitioners who put patients at risk. For the first time, continued registration with the Council will depend on maintenance of professional competence, in contrast to CPSM where continued registration was merely a matter of paying the annual fee after initial qualification. Furthermore, HPC has the power to deal with practitioners who are unfit to practice on health grounds, which was outside the remit of the CPSM statutes. Addition of new registered professions will be significantly easier under HPC, which now has its own authority to extend registration to new groups without the need for special legislation.
HPC will operate with four main Committees supported by an independent appeals mechanism. The Committees are Education and Training, responsible for approving training courses and setting professional standards; the Investigations Committee, responsible for the initial investigation of complaints against practitioners; the Health Committee, responsible for determination of allegations of unfitness to practise on health grounds; and the Conduct and Competence committee, responsible for judging allegations of unfitness to practice on grounds of misconduct, incompetence or failure to maintain competence. Although HPC became a statutory body in its own right on 1 April 2002, much detailed work needs to be done to establish the new HPC procedures and systems, and HPC will need to operate on the basis of the old CPSM rules and procedures until well into 2003.
One of the new procedures that will need to be devised and established is the mechanism by which clinical scientists will demonstrate maintenance of competence at regular (5 year) intervals for the purpose of maintaining their registration. It must be stressed that maintenance of competence is a broad term that includes continuing professional development (CPD) but is by no means confined to it. CPD has an important role in demonstrating that a practitioner has kept up to date with the changing demands of his or her subject and maintained the knowledge base essential for safe practice. However, maintenance of competence also encompasses issues such as practical ability (measured in terms of outcomes), effective working relationships with colleagues, ability to relate to patients and other areas not covered by CPD schemes. The GMC has developed a revalidation procedure for doctors that provides the opportunity to examine all these areas, and this is linked with the appraisal procedures operated by many employers (General Medical Council, 2001) . One of the priorities for HPC over the coming year will be to develop similar procedures for scientists and allied health professionals that are rigorous but sufficiently robust to cope with variations in professional practice across the different modalities. This will need to include some form of recognition of CPD schemes, such as that operated for clinical scientists in pathology by the Royal College of Pathologists.
Formal co-ordination between regulatory bodies in healthcare will be provided by the UK Council on Health Regulation (Department of Health, 2001d) , an overarching body responsible to Parliament for ensuring that standards of regulation are consistent across all the healthcare professions. The Council on Health Regulation will include representation from the General Medical Council, the General Dental Council, the General Optical Council, the Royal Pharmaceutical Society, the General Chiropractic Council and the new Health Professions Council and Nursing and Midwifery Council (Department of Health, 2001e) .
Conclusion
A range of overlapping changes and initiatives will transform healthcare science and the regulation and training of those who work in it over the next 10 years. Provided that these changes are properly linked together, adequately resourced and carried through to completion, they have the potential to revitalize the scientific service available to healthcare providers, and to deliver a service that can make healthcare more scientific, more efficient and better able to meet the needs of individual patients.
